MGP
Basic information
Region (hg38): 12:14880864-14885857
Links
Phenotypes
GenCC
Source:
- Keutel syndrome (Definitive), mode of inheritance: AR
- Keutel syndrome (Strong), mode of inheritance: AR
- Keutel syndrome (Supportive), mode of inheritance: AR
- Keutel syndrome (Strong), mode of inheritance: AR
- Keutel syndrome (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Keutel syndrome | AR | Cardiovascular | The condition can involve congenital cardiac anomalies, and awareness may allow early management | Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic | 6468443; 3717211; 2515061; 9674914; 9916809; 15810001 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (90 variants)
- Keutel_syndrome (16 variants)
- MGP-related_disorder (7 variants)
- not_specified (3 variants)
- Inborn_genetic_diseases (3 variants)
- Spondyloepiphyseal_dysplasia (1 variants)
- Short_palm (1 variants)
- Short_stature (1 variants)
- Platyspondyly (1 variants)
- Short_distal_phalanx_of_finger (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MGP gene is commonly pathogenic or not. These statistics are base on transcript: NM_000000900.5. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 14 | 15 | |||
| missense | 2 | 33 | 3 | 1 | 39 | |
| nonsense | 1 | 1 | 2 | |||
| start loss | 0 | |||||
| frameshift | 1 | 1 | 2 | |||
| splice donor/acceptor (+/-2bp) | 1 | 2 | 3 | 6 | ||
| Total | 3 | 4 | 39 | 17 | 1 |
Highest pathogenic variant AF is 0.000027304164
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| MGP | protein_coding | protein_coding | ENST00000228938 | 5 | 4746 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 125705 | 0 | 4 | 125709 | 0.0000159 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.116 | 69 | 71.8 | 0.962 | 0.00000442 | 826 |
| Missense in Polyphen | 30 | 28.762 | 1.043 | 325 | ||
| Synonymous | -0.201 | 27 | 25.7 | 1.05 | 0.00000167 | 227 |
| Loss of Function | 0.209 | 7 | 7.62 | 0.918 | 4.09e-7 | 88 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000123 | 0.000123 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.00 | 0.00 |
| Finnish | 0.00 | 0.00 |
| European (Non-Finnish) | 0.0000176 | 0.0000176 |
| Middle Eastern | 0.00 | 0.00 |
| South Asian | 0.00 | 0.00 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Associates with the organic matrix of bone and cartilage. Thought to act as an inhibitor of bone formation.;
- Disease
- DISEASE: Keutel syndrome (KTLS) [MIM:245150]: An autosomal recessive disorder characterized by abnormal cartilage calcification, peripheral pulmonary stenosis neural hearing loss and midfacial hypoplasia. {ECO:0000269|PubMed:9916809}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Warfarin Pathway, Pharmacodynamics;NOTCH1 regulation of human endothelial cell calcification;Endochondral Ossification;Validated transcriptional targets of AP1 family members Fra1 and Fra2
(Consensus)
Intolerance Scores
- loftool
- 0.545
- rvis_EVS
- 0.77
- rvis_percentile_EVS
- 86.95
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.539
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- cartilage condensation;ossification;cell differentiation;regulation of bone mineralization
- Cellular component
- extracellular matrix;collagen-containing extracellular matrix;extracellular exosome
- Molecular function
- extracellular matrix structural constituent;calcium ion binding;protein binding;structural constituent of bone